欢迎访问西亚试剂!
西亚试剂banner
西亚试剂banner
西亚试剂banner

当前位置:首页 > 新闻中心

西亚试剂:Activation of Liver X Receptor Induces Macrophage Interleuk

发布时间:2025-08-11

Activation of Liver X Receptor Induces Macrophage Interleukin-5 Expression

Yuanli Chen‡§, Yajun Duan‡§,1,2, Yanhua Kang‡§, Xiaoxiao Yang‡§, Meixiu Jiang‡§, Ling Zhang‡§, Guangliang Li‡§, Zhinan Yin‡§, Wenquan Hu‡§, Pengzhi Dong‡§, Xiaoju Li‡§, David P. Hajjar¶ and Jihong Han‡§,1,3

IL-5 stimulates production of T15/EO6 IgM antibodies that can block the uptake of oxidized low density lipoprotein by macrophages, whereas a deficiency in macrophage IL-5 expression accelerates development of atherosclerosis. Liver X receptors (LXRs) are ligand-activated transcription factors that can induce macrophage ABCA1 expression and cholesterol efflux, thereby inhibiting the development of atherosclerosis. However, it remains unknown whether additional mechanisms, such as the regulation of macrophage IL-5 expression, are related to the anti-atherogenic properties of LXR. We initially defined IL-5 expression in macrophages where the LXR ligand (T0901317) induced macrophage IL-5 protein expression and secretion. The overexpression of LXR increased, whereas its knockdown inhibited IL-5 expression. Furthermore, we found that LXR activation increased IL-5 transcripts, promoter activity, formation of an LXR·LXR-responsive element complex, and IL-5 protein stability. In vivo, we found that T0901317 increased IL-5 and total IgM levels in plasma and IL-5 expression in multiple tissues in wild type mice. In LDL receptor knock-out (LDLR−/−) mice, T0901317 increased IL-5 expression in the aortic root area. Taken together, our studies demonstrate that macrophage IL-5 is a target gene for LXR activation, and the induction of macrophage IL-5 expression can be related to LXR-inhibited atherosclerosis.

 

上一篇:三氟化硼乙醚生产方法
下一篇:西亚试剂:Genetic Dissection of TAM Receptor-Ligand Interaction in Re
版权所有:山东西亚化学有限公司

鲁ICP备20015914号-4